Study on relations between genetic polymorphisms in CYP2C19, GSTT 1 and risk of Kazakh's esophageal cancer in Xinjiang

Journal of Practical Oncology

Volumn 24, Issue 3, 2009, Pages

  Zhang, Li Wei ^a   Sheyhidin, Ilyar ^a   Wu, Ming Bai ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Enzymes; Esophageal neoplasms; Genes; Kazakh nationality; Polymorphism (genetics)

Indexed keywords

CARCINOGEN; CYTOCHROME P450 2C19; GLUTATHIONE TRANSFERASE T1;

ALLELE; ARTICLE; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 77953409423     PISSN: 10011692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cassom AG, Zheng Z, Chiassoh D, et al. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptybility to esophageal adenocarcinoma [J]. Cancer Detect Prev, 2003,27(9):139-146. (Pubitemid 36429594)
2. Butler WJ, Ryan P, Robers-Thomson IC. Metabolic genotypes and risk for colorectal cancer [J]. J Gastroenterol Hepatol, 2001,16(6):631-635. (Pubitemid 34188837)
3. Wrighton SA, Stevens JC, Becker GW, et al. Isolation and characterization of human liver cytochrome p4502C19: correlation between 2C19 and S- mephenytoin 4′-hydroxylation [J]. Arch Biochem Biophys, 1993,306(10):240-245. (Pubitemid 23291309)
4. de Morais SMF, Wickinson GR, Blaidell J, et al. Identification of a new genetic defect responsible for the polymorphism of S-mephenytoin metabolism in Japanese [J]. Mol Pharmacol, 1994,46(11):594-598. (Pubitemid 24334747)
5. Wang AH, Sun CS, Li LS, et al. Genetic susceptibility and environmental factors of exophageal cancer in Xi'an [J]. World J Gastroenterol, 2004,10(3):940-944. (Pubitemid 38461371)
6. Morita S, Yano M, Shiozaki H, et al. CYP1A1, CYP2E1 and GSTM, polymorphisms are not associated with susceptibility to squamous-cell carinoma of the esophagus [J]. Int J Cancer, 1997,71(4):192-195. (Pubitemid 27252989)
7. Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer [J]. Int J Cancer, 2001,95(6):240-246. (Pubitemid 32592091)